Non-interventional Study With Nab-Paclitaxel (Abraxane®)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Multi-peptide Vaccine With Basilixumab for Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
ErbB2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of LY3023414 in Participants With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway
- Status
- TERMINATED
- Phase
- NA
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
- Status
- TERMINATED
- Phase
- PHASE3
Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
- Status
- COMPLETED
- Phase
- NA
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of GTx024 in Women With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes
- Status
- COMPLETED
- Phase
- PHASE2
Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1